Why Is Capricor Therapeutics Stock Falling Friday? - Capricor Therapeutics (NASDAQ:CAPR)

Kaos Capital Calls on Capricor (NASDAQ: CAPR) Shareholders

Kaos Capital demands board reset and cash plan at Capricor after $80M burn in H1 2026 from single-asset bet and excessive G&A overhead. Governance lesson for biotech M&A: pipeline concentration without cash discipline triggers restructuring. Tech managers should assess similar risks in their own biotech partnerships and acquisitions.